Idoxuridine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for idoxuridine and what is the scope of freedom to operate?
Idoxuridine
is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Alcon, and Allergan, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for idoxuridine.
Summary for idoxuridine
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 4 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 115 |
| Clinical Trials: | 1 |
| Patent Applications: | 6,855 |
| DailyMed Link: | idoxuridine at DailyMed |
Recent Clinical Trials for idoxuridine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 2 |
| Rush University Medical Center | Phase 2 |
Medical Subject Heading (MeSH) Categories for idoxuridine
Anatomical Therapeutic Chemical (ATC) Classes for idoxuridine
US Patents and Regulatory Information for idoxuridine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | DENDRID | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 014169-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | HERPLEX | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 013935-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STOXIL | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 013934-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STOXIL | idoxuridine | OINTMENT;OPHTHALMIC | 015868-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
